Dermatology · Rochester, NY
NPI
1154775880
Since 2016
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
10 Hagen Dr Ste 300
Rochester, NY, 14625
Phone (585) 922-9770
Groups this clinician bills Medicare through
Medicare paid, 2024
$41K
1,381 services
Medicare patients, 2024
234
Average age 73
Drug cost, 2024
$3.9M
3,155 prescriptions
Company payments, 2025
$1,566
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David W Brodell was code 17003 (destruction skin lesion), 681 times for 96 patients. In total David W Brodell billed 1,381 services in 31 codes, and Medicare paid $41K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 681 | 96 | $3.73 | $2,541 |
| 99213 Office E&M - Established | Office | 245 | 181 | $56.11 | $14K |
| 17000 Destruction Skin Lesion | Office | 147 | 107 | $38.20 | $5,616 |
| 11102 Skin Biopsy | Office | 82 | 69 | $50.79 | $4,164 |
| 99214 Office E&M - Established | Office | 62 | 50 | $80.27 | $4,976 |
| 17110 Destruction Skin Lesion | Office | 36 | 32 | $60.44 | $2,176 |
| 11103 Skin Biopsy | Office | 36 | 23 | $27.64 | $995 |
| 99203 Office E&M - New | Office | 27 | 27 | $55.28 | $1,493 |
| 17004 Destruction Skin Lesion | Office | 14 | 11 | $91.23 | $1,277 |
By year: 2022 $27K for 799 services; 2023 $30K for 1,004 services; 2024 $41K for 1,381 services.
Medicare prescription drug claims, 2024
In 2024, the drug David W Brodell prescribed most often to Medicare patients was Triamcinolone Acetonide, with 462 prescriptions and refills. In total David W Brodell wrote 3,155 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 462 | 611 | 271 | $5,974 |
| Hydrocortisone Generic | 311 | 372 | 178 | $5,933 |
| Ketoconazole Generic | 301 | 327 | 129 | $4,917 |
| Doxycycline Hyclate Generic | 193 | 283 | 73 | $4,620 |
| Fluorouracil Generic | 185 | 198 | 151 | $12K |
| Clobetasol Propionate Generic | 133 | 144 | 77 | $4,480 |
| Dupixent Pen Dupilumab | 129 | 158 | 23 | $558K |
| Clindamycin Phosphate Generic | 129 | 130 | 43 | $5,426 |
| Metronidazole Generic | 126 | 133 | 64 | $6,379 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 99 | 99 | 34 | $2,444 |
| Fluocinonide Generic | 94 | 101 | 65 | $3,656 |
| Skyrizi Pen Risankizumab-Rzaa | 74 | 192 | 20 | $1.4M |
| Valacyclovir Valacyclovir Hcl | 60 | 104 | 24 | $2,542 |
| Otezla Apremilast | 53 | 57 | Under 11 | $266K |
| Minoxidil Generic | 51 | 75 | Under 11 | $576 |
Brand drugs: 449 claims; generic drugs: 2,706 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David W Brodell $1,566 ($1,566 in general payments such as food, travel and fees) from 13 companies. The largest payer was UCB, Inc. with $336.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 10 | $336 |
| Genzyme Corporation SNY | 4 | $261 |
| Galderma Laboratories, L.P. GALD.SW | 8 | $178 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $141 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $122 |
| Janssen Biotech, Inc. JNJ | 1 | $99 |
| Organon LLC OGN | 1 | $92.15 |
| Abbvie Inc. ABBV | 4 | $89.67 |
| Lilly USA, LLC LLY | 4 | $78.63 |
| Pfizer Inc. PFE | 1 | $75.14 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.